2m 2m 2m 2m 2m 2m 2m
ATTOVIA THERAP (ATTO)
NASDAQ
$13.87+$0.04 (+0.29%)
Price as of Oct 23, 2026 7:30 PM EDT- $661.9MMarket Cap
- N/A1-Year Change
- BiotechnologyIndustry
ATTOVIA THERAP (ATTO)
$13.87+$0.04 (+0.29%)
ATTO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $13.83 | ||
Change | -$0.67 (-4.62%) | ||
Open | $14.36 | ||
High | $14.75 | ||
Low | $13.53 | ||
Previous Close | $14.50 | ||
Volume | 312,939 | ||
30-Day Average Volume | 465,278 | ||
1-Week Change | 0.73% | ||
1-Month Change | -25.32% | ||
1-Year Change | N/A | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 45.7M | ||
Total Assets | $128.3M | ||
Market Cap | $661.9M | ||
Enterprise Value | $629.1M | ||
Period: QTR TTM FY | |||
Revenue | $450,000.00 | ||
Net Income | -$20.7M | ||
Free Cash Flow | N/A | ||
EBIT | -$20.7M | ||
EBITDA | -$20.5M | ||
Net Working Capital | N/A | ||
EPS | -$4.88 | ||
Enterprise Value/EBITDA | -31 | ||
Enterprise Value/Revenue | 1,398 | ||
P/B | -5 | ||
P/E | -3 | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 11/09/2017 | ||
Last Split Factor | 1 : 5.0270904666729 | ||
Last Split Date | 07/30/2020 | ||